Balchem Corp (FRA:BL9B)
€ 136.9 -1.2 (-0.87%) Market Cap: 4.55 Bil Enterprise Value: 4.65 Bil PE Ratio: 33.15 PB Ratio: 4.04 GF Score: 93/100

Q2 2025 Balchem Corp Earnings Call Transcript

Jul 31, 2025 / 03:00PM GMT
Release Date Price: €133.4 (+3.25%)

Key Points

Positve
  • Balchem Corp (BCPC) reported record second quarter consolidated sales of $255 million, a 9.1% increase from the prior year.
  • The company achieved record quarterly GAAP earnings from operations of $51 million, marking a 12.3% increase compared to the previous year.
  • The human nutrition and health segment delivered record sales of $161 million, driven by strong demand for nutrients and food ingredients.
  • Balchem Corp (BCPC) announced plans to build a new $36 million manufacturing facility, which will more than double its capacity for microencapsulation technologies.
  • The company is well-positioned to manage the current global trade environment, with a strong US manufacturing footprint and minimal reliance on China.
Negative
  • The increase in gross margin percent was partially offset by higher manufacturing input costs.
  • Consolidated operating expenses rose to $42 million, primarily due to higher compensation-related costs and professional services.
  • The company faces a $25 million impact from tariffs, which it plans to offset through supply chain adjustments and pricing strategies.
  • Balchem Corp (BCPC) is experiencing capacity constraints at its existing microencapsulation facility, necessitating the new facility investment.
  • The effective tax rate for the second quarter was 21.9%, slightly lower than the previous year, but still a significant expense.
Operator

Ladies and gentlemen, thank you for standing by. My name is Desiree, and I will be your conference operator today. At this time, I would like to welcome everyone to the Balkans second quarter 2025 earnings call. (Operator Instructions). I would now like to turn the conference over to Martin Bengtsson, Chief Financial Officer. You may begin.

Martin Bengtsson
Balchem Corp - Chief Financial Officer, Executive Vice President

Good morning everyone. Thank you for joining our conference call this morning to discuss the results of Balcom Corporation for the quarter ending June 30, 2025. My name is Martin Bengtsson, Chief Financial Officer, and hosting this call with me is Ted Harris, our Chairman, President, and CEO.

Following the advice of our council, auditors, and the FEC, at this time, I would like to read our forward-looking statements. Statements made in today's call that are not historical facts are considered forward-looking statements.

We can give no assurance that the expectations reflected in forward-looking statements will prove correct,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot